Silexion Therapeutics Reports 2025 Financial Results and Clinical Program Updates

robot
Abstract generation in progress

Silexion Therapeutics announced its financial results for the fourth quarter and full year 2025 on March 17, 2026, alongside updates on its business operations. The report highlighted revenue figures, operational developments, and progress in their clinical programs, including ongoing trials and research initiatives. The company also shared information about partnerships and strategic goals for the future.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
  • Reward
  • Comment
  • Repost
  • Share
Comment
Add a comment
Add a comment
No comments
  • Pin